Contact
Please use this form to send email to PR contact of this press release:
Paras Biopharma (Biologics CDMO) Maximises Recombinant Protein Expression Facilitating Economical Scale-up of Biologics
TO:
Mark Jackson
Paras Biopharmaceuticals Finland Oy
58442905993